Cite
HARVARD Citation
Dell'Aquila, E. et al. (n.d.). P-237Development of a new clinical nomogram including velocity rate of disease progression to predict outcome in metastatic colorectal cancer patients treated with bevacizumab beyond progression: A subanalysis from tribe trial. Annals of oncology. p. . [Online].